Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
Thank you for registering! Take a moment to confirm your subscription to MarketBeat Daily Ratings so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.

Belite Bio (BLTE) SEC Filings & 10K Form

$44.97
+2.59 (+6.11%)
(As of 05/17/2024 08:53 PM ET)

Recent Belite Bio SEC Filings

DateFilerForm TypeView
05/17/2024
10:36 AM
Belite Bio (Subject)
MATA NATHAN L. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2024
1:23 PM
Belite Bio (Subject)
Chiu Ching Chen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/13/2024
8:57 PM
Belite Bio (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2024
12:37 PM
Belite Bio (Filer)
Form 424B5
04/25/2024
8:02 PM
Belite Bio (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/22/2024
10:26 AM
Belite Bio (Subject)
Chen Wan-Shan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/22/2024
7:00 AM
Belite Bio (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
Must-See: Elon’s New Invention is Absolutely Insane (Ad)

Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.

Click here for the full story…
03/14/2024
2:58 PM
Belite Bio (Subject)
MATA NATHAN L. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2024
7:51 PM
Belite Bio (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/11/2024
8:05 PM
Belite Bio (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/11/2024
8:59 PM
Belite Bio (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/12/2024
8:08 PM
Belite Bio (Subject)
Lin Yu-Hsin (Filed by)
Form SC 13G
02/12/2024
7:40 PM
Belite Bio (Subject)
Lin Bioscience International Ltd. (Filed by)
Form SC 13G
12/28/2023
3:15 PM
Belite Bio (Subject)
Chuang Hao-Yuan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/28/2023
3:16 PM
Belite Bio (Subject)
Lin Yu-Hsin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/16/2023
3:36 PM
Belite Bio (Subject)
Lin Yu-Hsin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/16/2023
3:41 PM
Belite Bio (Subject)
Chuang Hao-Yuan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2023
7:00 AM
Belite Bio (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/19/2023
11:08 AM
Belite Bio (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/31/2023
4:16 PM
Belite Bio (Subject)
Lin Yu-Hsin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/09/2023
5:06 AM
Belite Bio (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/24/2023
5:07 AM
Belite Bio (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/16/2023
3:32 PM
Belite Bio (Filer)
Form 424B5
06/16/2023
3:36 PM
Belite Bio (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/30/2023
8:55 PM
Belite Bio (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/30/2023
11:15 PM
Belite Bio (Filer)
Form EFFECT
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:BLTE) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners